Filter
518
Filtered Results: 518
Text search:
recall
of
medicines
Featured
Recommendations
35
New Publications
163
Language
Document type
No document type
342
Studies & Reports
57
Guidelines
52
Manuals
37
Training Material
19
Strategic & Response Plan
5
Fact sheets
4
Situation Updates
1
Online Courses
1
Countries / Regions
India
33
Kenya
26
South Africa
21
Uganda
19
Global
18
Nepal
17
Malawi
17
Ethiopia
15
Zambia
15
Nigeria
10
Ghana
10
Liberia
9
Zimbabwe
8
Philippines
8
Bangladesh
8
Myanmar / Burma
8
Tanzania
7
Rwanda
7
Namibia
7
South–East Asia Region
7
Sierra Leone
6
Syria
4
Senegal
3
Cameroon
3
Sudan
3
Ukraine
3
Middle East and North Africa
3
Africa
3
Burkina Faso
2
Congo, Democratic Republic of
2
Mali
2
Haiti
2
Afghanistan
2
Indonesia
2
Botswana
2
Madagascar
2
Latin America and the Carribbean
2
Western and Central Europe
2
Asia
2
Venezuela
2
Southern Africa
2
Guinea
1
Jordan
1
Lebanon
1
Cambodia
1
Thailand
1
China
1
Mozambique
1
Benin
1
Central African Republic
1
Eswatini/ Swaziland
1
Burundi
1
Lesotho
1
Yemen
1
Western Pacific Region
1
Mongolia
1
Canada
1
Australia
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
232
Public Health
45
Clinical Guidelines
36
Capacity Building
29
Women & Child Health
25
Key Resources
20
Pharmacy & Technologies
3
Toolboxes
Mental Health
59
HIV
35
COVID-19
26
Pharmacy
26
Caregiver
22
TB
17
NCDs
17
Disability
14
Rapid Response
11
Ebola
10
Global Health Education
8
AMR
8
Conflict
5
Health Financing Toolbox
4
Cholera
3
Natural Hazards
3
Zika
3
Social Ethics
3
NTDs
3
Polio
2
Refugee
2
Specific Hazards
2
Planetary Health
2
This guidance should be followed if an unlicensed medicine is prepared in
a registered pharmacy. The preparation of an unlicensed medicine (for
...
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines...
Submitted to the US Agency for International Development by the
Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program.
This manual provides a framework to identify problems and design interventions to improve access to and use of...
Research globally has shown that metered dose inhaler (MDI) technique is poor,
with patient education and regular demonstration critical in maintaining correct use of
inhalers. Patient information containing pictorial aids improves understanding <... medicine
usage; however, manufacturer leaflets illustrating MDI use may not be easily understood by
low-literacy asthma patients.
Monitoring financial protection and utilization of health services in Mongolia 2009-2018 is based on national representative household socioeconomic surveys. The study finds that between 2009 and 2018, despite ambitious health reforms, the incidence...
The Access to Controlled Medications Programme identified the development of treatment guidelines that cover the treatment of all types of pain as...
WHO Technical Report Series, No. 961, 2011, Annex 8 - These guidelines are intended to provide a description of ways in which pharmacists can improve access to health care, health promotion and the use of<...
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
his manual is for people who have had no formal training in counselling but wish to learn the necessary components to establishing an effective counselling relationship. It will be useful for anyone who is involved in counselling people with a mental health problem.
h...
The Healthy Activity Program manual aims at providing counsellors like you with information about counselling patients with moderate to severe Depression in primary care settings.
Under-diagnosis of asthma in ‘under-fives’ may be alleviated by improved inquiry into disease history. We assessed a questionnaire-based screening tool for asthma among 614 ‘under-fives’ with severe respiratory illness in Uganda. The questio...
The Ideal Clinic Realisation and Maintenance (ICRM) programme was initiated by the National Department of Health in July 2013 in order to systematically improve primary health care (PHC) facilities and the quality ... care they provide. The Ideal Clinic framework/dashboard sets out the standards for PHC facilities to provide good-quality health services. An Ideal Clinic is defined as a clinic with good infrastructure, adequate staff, adequate medicines and supplies, good administrative processes, and sufficient adequate bulk supplies. Applicable clinical policies, protocols and guidelines are adhered to, and it harnesses partner and stakeholder support.
Good Manufacturing Practice (GMP) describes a set of principles and procedures that, when followed, ensure that medicines and related substances are of...
Licensed pharmaceutical products (marketing authorization) should be manufactured only by licensed manufacturers (holders of a manufacturing authorization) whose activities are regularly inspected by competent national authorities. This guide to GMP...
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of ... in Nigeria.
At least half of the world’s population does not have full coverage of essential health services. Health expenses push more than 100 million people into extreme poverty each and every year, forcin...
The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions to improve the prevention, detection and management ... cardiovascular diseases and provide a generic global framework available for local adaptation. A first Roadmap on raised blood pressure was published in 2015. Since then, advances in hypertension have included the publication of new clinical guidelines (AHA/ACC; ESC; ESH/ISH); the launch of the WHO Global HEARTS Initiative in 2016 and the associated Resolve to Save Lives (RTSL) initiative in 2017; the inclusion of single-pill combinations on the WHO Essential
Medicines’ list as well as various advances in technology, in particular telemedicine and mobile health. Given the substantial benefit accrued from effective interventions in the management of hypertension and their potential for scalability in low and middle-income countries (LMICs), the WHF has now revisited and updated the ‘Roadmap for raised BP’ as ‘Roadmap for hypertension’
by incorporating new developments in science and policy. Even though cost-effective lifestyle and medical interventions to prevent and manage hypertension exist, uptake is still low, particularly in resource-poor areas. This Roadmap examined the roadblocks pertaining to both the demand side (demographic and socio-economic factors, knowledge and beliefs, social relations, norms, and
traditions) and the supply side (health systems resources and processes) along the patient pathway to propose a range of possible solutions to overcoming them. Those include the development of population-wide prevention and control programmes; the implementation of opportunistic screening and of out-of-office blood pressure measurements; the strengthening of primary care and a greater focus on task sharing and team-based care; the delivery of people-centred care and stronger patient and carer education; and the facilitation of adherence to treatment. All of the above are dependent upon the availability and effective distribution of good quality, evidencebased, inexpensive BP-lowering agents.
Background
Asthma remains highly prevalent, with more severe symptoms in low-income to middle-income countries (LMICs) compared with high-income countries. Identifying risk factors for severe asthma symptoms can assist with improving outcomes. We aimed to determine the prevalence, severity and ris...
